Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Shareholder value

<< Previous

Bullboard Posts

Next >>

Comment by checkupon Nov 23, 2023 9:55am

80 Views

Post# 35749891

RE:RE:RE:RE:Shareholder value

At one point (in the beginning) LABS stood out from the crowd because of its strategic managing of its business. I don't think a reverse split would do any good. 10 to 1 would leave 39 million shares outstanding and a share price of .60 cents. A buyout is probably the best we'll get.

It is being affected by tax loss selling too. The business segment would benefit from reasonable government regulations but with the utterly incompetent government we have, that won't happen.

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition